(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study of two topical gels is for people who have blotchy, red skin across the face from rosacea. The trial will last for 12 weeks, with four office visits.
The research site is in Plano, Texas.
This study for people 18 and older will evaluate a once-daily investigational drug for ulcerative colitis. This study will last for 14 months.
The research site is in Sandy, Utah.
This study will evaluate an investigational medication for schizophrenia. Candidates must be 18 to 64 and currently being treated with Zyprexa, Risperdal or Abilify. The research site is in Cherry Hill, N.J.
Copyright 2011 ClinicalConnection.com. All rights reserved.